Latest Insider Transactions at Mirion Technologies, Inc. (MIR)
This section provides a real-time view of insider transactions for Mirion Technologies, Inc. (MIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mirion Technologies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mirion Technologies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2024
|
Alison Ulrich Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,859
-8.24%
|
$31,449
$11.37 P/Share
|
|
Apr 01
2024
|
Thomas D Logan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,098
-6.91%
|
$617,078
$11.37 P/Share
|
|
Mar 28
2024
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,679
+4.23%
|
-
|
|
Mar 28
2024
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,898
+3.25%
|
-
|
|
Mar 28
2024
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,898
+3.25%
|
-
|
|
Mar 28
2024
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,227
+3.84%
|
-
|
|
Mar 20
2024
|
Brian Schopfer Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
90,910
-30.1%
|
$1,000,010
$11.0 P/Share
|
|
Mar 20
2024
|
Brian Schopfer Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90,910
-12.27%
|
-
|
|
Mar 20
2024
|
Brian Schopfer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,910
+23.13%
|
-
|
|
Mar 01
2024
|
Emmanuelle Lee Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,060
+12.26%
|
-
|
|
Mar 01
2024
|
Alison Ulrich Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,040
+22.45%
|
-
|
|
Mar 01
2024
|
Brian Schopfer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,240
+22.2%
|
-
|
|
Mar 01
2024
|
Thomas D Logan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
156,626
+16.17%
|
-
|
|
Mar 01
2024
|
Christopher A. Moore Chief Accounting Officer (PAO) |
BUY
Grant, award, or other acquisition
|
Direct |
7,530
+15.93%
|
-
|
|
Mar 01
2024
|
Loic Eloy Technologies Group President |
BUY
Grant, award, or other acquisition
|
Direct |
20,080
+9.13%
|
-
|
|
Dec 29
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,435
+4.35%
|
-
|
|
Dec 29
2023
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,835
+4.81%
|
-
|
|
Dec 29
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+3.66%
|
-
|
|
Dec 29
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+3.66%
|
-
|
|
Dec 27
2023
|
Brian Schopfer Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,606
-5.39%
|
$86,060
$10.45 P/Share
|
|
Dec 27
2023
|
Thomas D Logan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,309
-6.73%
|
$473,090
$10.45 P/Share
|
|
Nov 01
2023
|
Michael J Rossi Medical Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,514
-4.53%
|
$33,084
$6.93 P/Share
|
|
Sep 29
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+5.24%
|
-
|
|
Sep 29
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,410
+6.26%
|
-
|
|
Sep 29
2023
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,570
+6.93%
|
-
|
|
Sep 29
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+5.24%
|
-
|
|
Jun 30
2023
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,340
+4.68%
|
-
|
|
Jun 30
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,646
+5.06%
|
-
|
|
Jun 30
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,646
+5.06%
|
-
|
|
Jun 30
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,340
+4.68%
|
-
|
|
Jun 06
2023
|
Sheila Rege Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+36.05%
|
-
|
|
Jun 06
2023
|
Lawrence D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+27.06%
|
-
|
|
Jun 06
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.74%
|
-
|
|
Jun 06
2023
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+27.06%
|
-
|
|
Jun 06
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.12%
|
-
|
|
Jun 06
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.12%
|
-
|
|
Jun 06
2023
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,850
+20.74%
|
-
|
|
May 30
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
SELL
Open market or private sale
|
Direct |
3,430
-9.63%
|
$24,010
$7.92 P/Share
|
|
May 23
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
BUY
Grant, award, or other acquisition
|
Direct |
6,353
+15.13%
|
-
|
|
Apr 01
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
1,733
-5.59%
|
$13,864
$8.54 P/Share
|
|
Apr 01
2023
|
Brian Schopfer Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,451
-4.46%
|
$59,608
$8.54 P/Share
|
|
Apr 01
2023
|
Thomas D Logan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,862
-4.99%
|
$294,896
$8.54 P/Share
|
|
Mar 31
2023
|
Jody Markopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+6.42%
|
-
|
|
Mar 31
2023
|
John W Kuo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,596
+6.87%
|
-
|
|
Mar 31
2023
|
Kenneth Bockhorst Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+6.42%
|
-
|
|
Mar 31
2023
|
Steven W. Etzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,596
+6.87%
|
-
|
|
Mar 29
2023
|
Christopher A. Moore Chief Accounting Officer (PAO) |
BUY
Grant, award, or other acquisition
|
Direct |
15,527
+33.36%
|
-
|
|
Mar 29
2023
|
Loic Eloy Technologies Group President |
BUY
Grant, award, or other acquisition
|
Direct |
16,645
+8.48%
|
-
|
|
Mar 29
2023
|
Michael J Rossi Medical Group President |
BUY
Grant, award, or other acquisition
|
Direct |
41,242
+25.31%
|
-
|
|
Mar 29
2023
|
Brian Schopfer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,689
+22.93%
|
-
|